PBS listing for leukaemia drug

The government has announced the PBS listing of a treatment for chronic myeloid leukaemia and acute lymphoblastic leukaemia.

Ponatinib (marketed as Iclusig) is indicated for:

  • CML patients who have failed at least two prior tyrosine kinase inhibitors or where there is a T315L mutation